Company News /
by Adrian Tan -
3 months ago
18 Dec 2024 - Clarity Pharmaceuticals (ASX:CU6) has developed a novel radiopharmaceutical called "SAR-bisFAP", a product that could be used for both diagnosis and treatment, with "…
Company Presentations /
by Finance News Network -
2 years ago
05 Dec 2022 - Dr Alan Taylor - Executive Chairperson - Clarity's mission is to develop next-generation radiopharmaceutical products that improve treatment outcomes for children and…
